Last reviewed · How we verify
NCT06022835
Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis
NA trial testing Chlorhexidine Gluconate-gel (CHG) Dressing in Peritoneal Dialysis Catheter Exit Site Infection in 30 participants. Completed in 31 July 2023.
31 July 2023
Quick facts
| Lead sponsor | National Healthcare Group, Singapore |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 27 September 2019 |
| Primary completion | 31 July 2023 |
| Estimated completion | 31 July 2023 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Chlorhexidine Gluconate-gel (CHG) Dressing
Conditions studied
- Peritoneal Dialysis Catheter Exit Site Infection — all drugs for Peritoneal Dialysis Catheter Exit Site Infection →
- End Stage Renal Disease on Dialysis — all drugs for End Stage Renal Disease on Dialysis →
- Dialysis; Complications — all drugs for Dialysis; Complications →
Sponsor
National Healthcare Group, Singapore
Who can join
Adults 21 to 99, any sex, with Peritoneal Dialysis Catheter Exit Site Infection or End Stage Renal Disease on Dialysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Exit site infection (ESI) is one of the major predisposing factors to peritoneal dialysis (PD) related peritonitis. Chlorhexidine Gluconate (CHG) has been widely used for cutaneous disinfection for half a century. TegadermTM CHG is a water-proof dressing with gel pads that provide 2% CHG to the skin surface and effectively prevents catheter-related infections for intravascular catheters. However, its use has not been accessed in patients with PD catheters. We aim to evaluate the effectiveness of TegadermTM CHG dressing in preventing ESI in PD patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06022835
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peritoneal Dialysis Catheter Exit Site Infection
Currently open trials in the same condition.
- NCT05143164 — Hydrocolloid Dressing for Catheter Exit Site Care in Peritoneal Dialysis Patients · NA · active not recruiting
Other National Healthcare Group, Singapore trials
Trials by the same sponsor.
- NCT05410691 — Handheld Ultrasound-guided Cannulation of Difficult Haemodialysis Arteriovenous Access by Renal Nurses · NA · completed
- NCT06802679 — Comparison of Standard Versus High Dose Urokinase for Dysfunctional Tunneled Dialysis Catheters in Haemodialysis Patient · Phase 4 · completed
- NCT03273140 — The Effectiveness of Gamification Diabetes Education Program for Poorly Controlled Type 2 Diabetic Patients · NA · completed
- NCT03181906 — Effectiveness of Pre-Consultation Medication Reconciliation Service in Reducing Unintentional Medication Discrepancies D · NA · completed
- NCT01257711 — A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06022835 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Healthcare Group, Singapore
- Last refreshed: 5 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06022835.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing